论文部分内容阅读
目的 :评价经皮左锁骨下动脉穿刺植入药盒在晚期恶性肿瘤治疗中的应用价值。方法 :对 2 0 0例晚期恶性肿瘤病人采用经皮左锁骨下动脉穿刺植入药盒治疗。依据肿瘤供血情况 ,在透视监控下 ,施行药盒植入术。术后经药盒行规则性化疗或碘油化疗乳剂栓塞。结果 :2 0 0例患者共植植入 2 0 2个药盒。植入成功率为99%。并发症有 9例 (4 .5 % )。无严重并发症。结论 :经皮左锁骨下动脉穿刺行药盒植入术安全可行、操作简便易行、创伤小 ,为动脉内化疗灌注和碘油化疗乳剂栓塞提供了一条安全可靠的途径
Objective: To evaluate the value of percutaneous left subclavian artery puncture implantation kit in the treatment of advanced malignancies. Method: Percutaneous left subclavian artery puncture implant kit was used to treat 200 patients with advanced malignant tumor. According to the tumor blood supply, under the perspective of monitoring, the implementation of kit implantation. Postoperative chemotherapy by prescription or regular chemotherapy of lipiodol emulsion embolism. Results: A total of 220 cases were implanted in 200 patients. Implant success rate was 99%. Complications in 9 cases (4.5%). No serious complications. CONCLUSION: Percutaneous left subclavian puncture is feasible and safe in operation. The operation is simple and easy to operate with less trauma. It provides a safe and reliable way for intra-arterial chemoembolization and lipiodol chemoembolization